Bone Marrow TransplantationTissue DonorsTransplantation, HomologousHistocompatibility TestingGraft vs Host DiseaseHistocompatibilityBone MarrowGraft SurvivalBone Marrow CellsTransplantation ChimeraImmunization, PassiveWhole-Body IrradiationTransplantation, AutologousTransplantation ConditioningT-LymphocytesSurvival AnalysisAnemia, AplasticLeukemiaHematopoietic Stem Cell TransplantationBone and BonesImmunity, CellularGraft RejectionTransplantation, IsogeneicLiver TransplantationRadiation ChimeraGraft Enhancement, ImmunologicTransplantation ToleranceHematopoietic Stem CellsMice, Inbred C57BLKidney TransplantationImmunosuppressive AgentsLeukocyte TransfusionBusulfanSkin TransplantationImmunosuppressionBone Marrow PurgingRecurrenceHLA AntigensTransplantation ImmunologyLymphocyte DepletionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveChimerismTreatment OutcomeHeart TransplantationTime FactorsActuarial AnalysisCyclophosphamidePrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow DiseasesHematopoiesisAcute DiseaseCombined Modality TherapyLeukemia, Myeloid, AcuteBone Marrow ExaminationLymphocyte Culture Test, MixedMice, Inbred BALB CHematologic NeoplasmsRemission InductionChimeraHepatic Veno-Occlusive DiseaseBone RemodelingGraft vs Host ReactionImmune ToleranceBone Marrow NeoplasmsLiving DonorsLeukemia, MyeloidStem Cell TransplantationLymphocyte TransfusionLymphoma, Non-HodgkinDisease-Free SurvivalSevere Combined ImmunodeficiencyColony-Forming Units AssayRetrospective StudiesMyelodysplastic SyndromesLung TransplantationMice, Inbred C3HCyclosporineFlow CytometryHematologic DiseasesBlood DonorsSpleenBone DensityOrgan TransplantationNuclear FamilyCell DifferentiationAntineoplastic Combined Chemotherapy ProtocolsGraft vs Tumor EffectCarmustineLeukocyte CountFollow-Up StudiesPancytopeniaCytomegalovirus InfectionsSurvival RateCells, CulturedGraft vs Leukemia EffectImmune SystemCytarabineGranulocyte Colony-Stimulating FactorBone ResorptionMelphalan